Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap (NYSE:DLB)
· seekingalpha.com
With high margins, a robust buyback program, and an undervalued share price despite weak growth, I rate Dolby Laboratories a buy. Click to know more on the DLB stock.
The author is a director at a small Boston-based software company where he oversees India operations across HR, finance, and business development. His broader p...